Stay updated on Carfilzomib Combo for Myeloma Clinical Trial

Sign up to get notified when there's something new on the Carfilzomib Combo for Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carfilzomib Combo for Myeloma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T01:19:35.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A banner was added announcing NIH website updates and explaining that some NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T01:27:22.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1. The study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:06:26.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T01:38:51.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the study content with a standard error view, indicating restricted access to the record rather than a substantive update to the study information.
    Difference
    19%
    Check dated 2026-09-20T00:26:21.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page would remove the 'Multiple myeloma' condition label and the 'related topics:' header, along with the 'MedlinePlus Genetics' link from the study record. This reduces disease-specific navigation and related resources while leaving the primary trial details intact.
    Difference
    0.2%
    Check dated 2026-09-05T22:15:58.000Z thumbnail image

Stay in the know with updates to Carfilzomib Combo for Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carfilzomib Combo for Myeloma Clinical Trial page.